The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Sunitinib Accord 37.5 mg hard capsules



Accord Healthcare S.L.U.EU/1/20/1511/007-009

Main Information

Trade NameSunitinib Accord 37.5 mg hard capsules
Active SubstancesSunitinib
Dosage FormCapsule, hard
Licence HolderAccord Healthcare S.L.U.
Licence NumberEU/1/20/1511/007-009

Group Information

ATC CodeL01XE04 sunitinib

Status

License statusAuthorised
Licence Issued11/02/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable ListSunitinib 37.5mg Capsules
Interchangeable List CodeIC0147-063-001
Interchangeable List DocumentPDF of Interchangeable List
« Back